Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...

Good day, and welcome to the Accuray fiscal 2025, second quarter financial results conference call. All participants will be in a listen-only mode. (Operator Instructions). I would now like to turn ...

Operator: Good day, and welcome to the Accuray Fiscal 2025 Second Quarter Financial Results Conference Call. All participants ...

CyberKnife radiosurgery is a 15-minute outpatient procedure that requires no anesthesia or hospital admission, offering a non ...

Q2 2025 Management View Suzanne Winter, CEO, highlighted an 8% year-over-year revenue growth for Q2, supported by robust product revenue growth of 19%, and a strong adjusted EBITDA performance of ...

Reports Q2 revenue $116.2M, consensus $110.36M. “Our strong Q2 performance reflects outstanding execution of our strategies of advancing ...

A new state of the art comprehensive cancer centre is set to open in the coming years, marking a significant step forward in ...

AHMEDABAD: To deal with deadly diseases like cancer in the country, the government is trying its best to cure people by ...

Tribune News NetworkDohaThe National Center for Cancer Care and Research (NCCCR) at Hamad Medical Corporation (HMC) is at the forefront of cancer treatment in Qatar and the region, setting new ...

DOHA: The National Center for Cancer Care and Research (NCCCR) at Hamad Medical Corporation is at the forefront of cancer treatment in Qatar and the region, setting new ...

Sindh Syed Murad Ali Shah on Wednesday directed the Secretary Health and the Executive Director of Sehwan Hospital ...